文献速递炎症性肠病消化内镜消化道肿瘤与早癌

高危结直肠结肠炎相关肿瘤患者的内镜管理:一项德尔菲研究

Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia: a Delphi study.
PubMed 文献 · Gastrointest Endosc · 2022-12-09

本研究采用三轮改良德尔菲法,在全球3大洲18名炎症性肠病和/或内镜专家中达成共识,共14条陈述全部达成共识。专家就结直肠结肠炎相关肿瘤(CAN)及高危CAN(HR-CAN)的定义、切除前增强内镜成像检查、内镜可切除性评估、内镜评估与标准报告、切除类型、内镜成功、组织学评估和随访达成共识。结论认为这是制定国际共识推荐的第一步,尽管现有证据质量被认为较低。

要点

  • 专家就CAN和HR-CAN的定义达成共识。
  • 切除前应使用增强内镜成像检查结肠。
  • 专家就HR-CAN的切除类型、内镜成功、组织学评估和随访达成共识。

核心结论

  • 这是制定CAN和HR-CAN内镜管理国际共识推荐的第一步。
  • 尽管现有证据质量被认为较低,专家在CAN和HR-CAN管理的多个方面达成共识。
  • 本项工作及提出的标准化可能有益于未来研究。

研究设计与样本

  • 采用三轮改良德尔菲法,在全球3大洲的18名炎症性肠病和/或内镜专家中达成共识。
  • 共识定义为≥75%同意或不同意。
  • 证据质量采用Cochrane协作组标准评估。

主要发现

  • 全部14条陈述均达成共识。
  • 专家就CAN和HR-CAN的定义达成共识。
  • 专家就切除前使用增强内镜成像检查结肠达成共识。
  • 专家就HR-CAN病灶的内镜可切除性、内镜评估和CAN病灶的标准报告达成共识。
  • 专家就HR-CAN的切除类型(<20 mm、>20 mm,伴或不伴良好抬举)、内镜成功(技术成功和结局)、组织学评估和随访达成共识。

关键数值与推荐

  • 共识阈值为≥75%同意或不同意。
  • HR-CAN切除类型按病灶大小分为<20 mm和>20 mm,并区分伴或不伴良好抬举。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 现有证据质量被认为较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Current guidelines recommend endoscopic resection of visible and endoscopically resectable colorectal colitis-associated neoplasia (CAN) in patients with inflammatory bowel disease (IBD). However, patients with high-risk CAN (HR-CAN) are often not amenable to conventional resection techniques, and a consensus approach for the endoscopic management of these lesions is presently lacking. This Delphi study aims to reach consensus among experts on the endoscopic management of these lesions. METHODS: A 3-round modified Delphi process was conducted to reach consensus among worldwide IBD and/or endoscopy experts (n = 18) from 3 continents. Consensus was considered if ≥75% agreed or disagreed. Quality of evidence was assessed by the criteria of the Cochrane Collaboration group. RESULTS: Consensus was reached on all statements (n = 14). Experts agreed on a definition for CAN and HR-CAN. Consensus was reached on the examination of the colon with enhanced endoscopic imaging before resection, the endoscopic resectability of an HR-CAN lesion, and endoscopic assessment and standard report of CAN lesions. In addition, experts agreed on type of resections of HR-CAN (< 20 mm, >20 mm, with or without good lifting), endoscopic success (technical success and outcomes), histologic assessment, and follow-up in HR-CAN. CONCLUSIONS: This is the first step in developing international consensus-based recommendations for endoscopic management of CAN and HR-CAN. Although the quality of available evidence was considered low, consensus was reached on several aspects of the management of CAN and HR-CAN. The present work and proposed standardization might benefit future studies.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bak MTJ, Albéniz E, East JE, et al. Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia: a Delphi study. Gastrointest Endosc. 2022. PMID: 36509111. doi:10.1016/j.gie.2022.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。